PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy
Source abstract
Abstract
Drug delivery systems for cancer chemotherapy are employed to improve the effectiveness and decrease the side-effects of highly toxic drugs. Most chemotherapy agents have indiscriminate cytotoxicity that affects normal, as well as cancer cells. To overcome these problems, new more efficient nanosystems for drug delivery are increasingly being investigated. Polyamidoamine (PAMAM) dendrimers are an example of a versatile and reproducible type of nanocarrier that can be loaded with drugs, and modified by attaching target-specific ligands that recognize receptors that are over-expressed on cancer cells. PAMAM dendrimers with a high density of cationic charges display electrostatic interactions with nucleic acids (DNA, siRNA, miRNA, etc.), creating dendriplexes that can preserve the nucleic acids from degradation. Dendrimers are prepared by conducting several successive "generations" of synthetic reactions so their size can be easily controlled and they have good uniformity. Dendrimers are particularly well-suited to co-delivery applications (simultaneous delivery of drugs and/or genes). In the current review, we discuss dendrimer-based targeted delivery of drugs/genes and co-delivery systems mainly for cancer therapy.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Dendrimers and Hyperbranched Polymers · RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3, 4-difluorobenzylidene curcumin to CD44 overexpressing pancreatic cancer cells10.1016/j.colsurfb.2015.09.043 ↗
2. Nanoparticle-mediated co-delivery of chemotherapeutic agent and siRNA for combination cancer therapy10.1080/17425247.2016.1205583 ↗
3. Clinical application of drug delivery systems in cancer chemotherapy: review of the efficacy and side effects of approved drugs10.1248/bpb.b12-01102 ↗
4. Effect of adriamycin on heart mitochondrial DNA10.1042/bj2450309 ↗
5. Formulation, characterization, and geno/cytotoxicity studies of galbanic acid-loaded solid lipid nanoparticles10.3109/13880209.2014.991836 ↗
6. Solid lipid-based nanocarriers as efficient targeted drug and gene delivery systems10.1016/j.trac.2015.12.016 ↗
7. Targeted cancer therapy through antibody fragments-decorated nanomedicines10.1016/j.jconrel.2017.10.036 ↗
8. Receptor mediated tumor targeting: an emerging approach for cancer therapy10.2174/156720111793663606 ↗
9. Bacterial-derived biopolymers: advanced natural nanomaterials for drug delivery and tissue engineering10.1016/j.trac.2016.06.013 ↗
10. Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems10.1039/C5CS00798D ↗
11. Dendrimers: synthesis, applications, and properties10.1186/1556-276X-9-247 ↗
12. Formulation, characterization and cytotoxicity studies of alendronate sodium-loaded solid lipid nanoparticles10.1016/j.colsurfb.2014.01.055 ↗
13. Drug targeting using solid lipid nanoparticles10.1016/j.chemphyslip.2014.03.006 ↗
14. Preparation of dry powder inhaler of montelukast sodium-loaded solid lipid nanoparticles and evaluation of its physicochemical characteristics
15. Formulation and characterization of ethambutol loaded nanostructured lipid carrier
16. Biodegradable nano-polymers as delivery vehicles for therapeutic small non-coding ribonucleic acids10.1016/j.jconrel.2016.11.017 ↗
17. A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancer10.1016/j.lungcan.2013.08.002 ↗
18. Restoration of chemosensitivity by multifunctional micelles mediated by P-gp siRNA to reverse MDR10.1016/j.biomaterials.2014.06.035 ↗
19. Multifunctional polymeric micelles for delivery of drugs and siRNA10.3389/fphar.2014.00077 ↗
20. Nanoparticle delivery of cancer drugs10.1146/annurev-med-040210-162544 ↗
21. Advances and challenges of liposome assisted drug delivery10.3389/fphar.2015.00286 ↗
22. Jasmine · 2013
23. Nano graphene oxide: a novel carrier for oral delivery of flavonoids10.1016/j.colsurfb.2014.09.036 ↗
24. Development of dry powder inhaler formulation loaded with alendronate solid lipid nanoparticles: solid-state characterization and aerosol dispersion performance10.3109/03639045.2014.956111 ↗
25. Microparticles containing erlotinib-loaded solid lipid nanoparticles for treatment of non-small cell lung cancer10.1080/03639045.2017.1310223 ↗
26. Solid lipid nanoparticles as efficient drug and gene delivery systems: recent breakthroughs10.15171/apb.2015.022 ↗
27. Dendrimer-based nanodevices for targeted drug delivery applications10.1039/c3tb20724b ↗
28. Birth of a new macromolecular architecture: dendrimers as quantized building blocks for nanoscale synthetic polymer chemistry10.1016/j.progpolymsci.2005.01.007 ↗
29. Stimuli-responsive dendrimers in drug delivery10.1039/C5BM00532A ↗
30. Dendrimers in cancer treatment and diagnosis
31. Dendrimers as tunable vectors of drug delivery systems and biomedical and ocular applications
32. PAMAM dendrimers as promising nanocarriers for RNAi therapeutics10.1016/j.mattod.2015.06.003 ↗
33. Dendrimers in combination with natural products and analogues as anti-cancer agents10.1039/C7CS00550D ↗
34. Dendrimers: emerging polymers for drug-delivery systems10.1016/j.ejps.2009.07.008 ↗
35. Therapeutic and diagnostic applications of dendrimers for cancer treatment10.1016/j.addr.2008.02.012 ↗
36. Poly (amidoamine) (PAMAM) nanoparticles: synthesis and biomedical applications
37. Modified PAMAM dendrimer with 4-carbomethoxypyrrolidone surface groups-its uptake, efflux, and location in a cell10.1016/j.colsurfb.2017.07.052 ↗
38. Modified PAMAM dendrimer with 4-carbomethoxypyrrolidone surface groups reveals negligible toxicity against three rodent cell-lines10.1016/j.nano.2013.01.010 ↗
39. Poly (amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications10.1016/S1359-6446(01)01757-3 ↗
40. Lipid modified triblock PAMAM-based nanocarriers for siRNA drug co-delivery10.1016/j.biomaterials.2012.10.024 ↗
41. Poly (amidoamine) dendrimers as a pharmaceutical excipient. Are we there yet?10.1016/j.xphs.2017.10.011 ↗
42. Targeted delivery of doxorubicin into cancer cells using a folic acid–dendrimer conjugate10.1039/c1py00179e ↗
43. Encapsulation of 2-methoxyestradiol within multifunctional poly (amidoamine) dendrimers for targeted cancer therapy10.1016/j.biomaterials.2010.12.060 ↗
44. Multifunctional lactobionic acid-modified dendrimers for targeted drug delivery to liver cancer cells: investigating the role played by PEG spacer10.1021/am504849x ↗
45. RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells10.1016/j.colsurfb.2014.11.004 ↗
46. Encapsulation of doxorubicin within multifunctional gadolinium-loaded dendrimer nanocomplexes for targeted theranostics of cancer cells10.1039/C5RA01215E ↗
47. Impact of dendrimer surface functional groups on the release of doxorubicin from dendrimer carriers10.1021/jp411669k ↗
48. Synthesis of polyamidoamine dendrimers having poly (ethylene glycol) grafts and their ability to encapsulate anticancer drugs10.1021/bc0000583 ↗
49. Doxorubicin–PAMAM dendrimer complex attached to liposomes: cytotoxic studies against human cancer cell lines10.1016/j.ijpharm.2005.05.039 ↗
50. Dendrimers as carriers for delivery of chemotherapeutic agents10.1021/cr900174j ↗
51. Dendrimer-based nanocarriers: a versatile platform for drug delivery10.1002/wnan.1409 ↗
52. Targeted delivery of methotrexate to epidermal growth factor receptor–positive brain tumors by means of cetuximab (IMC-C225) dendrimer bioconjugates10.1158/1535-7163.MCT-05-0325 ↗
53. Dendrimer-platinate: a novel approach to cancer chemotherapy10.1097/00001813-199909000-00010 ↗
54. Dendrimer-entrapped gold nanoparticles modified with RGD peptide and alpha-tocopheryl succinate enable targeted theranostics of cancer cells10.1016/j.colsurfb.2015.05.040 ↗
55. Multifunctional dendrimers modified with alpha-tocopheryl succinate for targeted cancer therapy10.1039/C3MD00324H ↗
56. Targeted cancer theranostics using alpha-tocopheryl succinate-conjugated multifunctional dendrimer-entrapped gold nanoparticles10.1016/j.biomaterials.2014.05.046 ↗
57. Activity of dendrimer–methotrexate conjugates on methotrexate-sensitive and-resistant cell lines10.1021/bc0501855 ↗
58. Drug release characteristics of PAMAM dendrimer–drug conjugates with different linkers10.1016/j.ijpharm.2009.10.017 ↗
59. Dendrimeric anticancer prodrugs for targeted delivery of ursolic acid to folate receptor-expressing cancer cells: synthesis and biological evaluation10.1016/j.ejps.2015.01.007 ↗
60. Dendronized heparin–doxorubicin conjugate based nanoparticle as pH-responsive drug delivery system for cancer therapy10.1016/j.biomaterials.2012.12.017 ↗
61. Mechanisms of drug release in nanotherapeutic delivery systems10.1021/cr5004634 ↗
62. Hydrazone linkages in pH responsive drug delivery systems10.1016/j.ejps.2016.12.011 ↗
63. Synthesis and characterization of DOX-conjugated dendrimer-modified magnetic iron oxide conjugates for magnetic resonance imaging, targeting, and drug delivery10.1039/c2jm16792a ↗
64. PEGylated PAMAM dendrimer-doxorubicin conjugates: in vitro evaluation and in vivo tumor accumulation10.1007/s11095-009-9992-1 ↗
65. Design of a paclitaxel prodrug conjugate for active targeting of an enzyme upregulated in breast cancer cells10.1021/mp500128k ↗
66. Real-time monitoring of glutathione-triggered thiopurine anticancer drug release in live cells investigated by surface-enhanced Raman scattering10.1021/ac2024188 ↗
67. Subcellular compartmentalization of glutathione: correlations with parameters of oxidative stress related to genotoxicity10.1093/mutage/gel043 ↗
68. A poly (amidoamine) dendrimer-based nanocarrier conjugated with Angiopep-2 for dual-targeting function in treating glioma cells10.1039/C5PY01625H ↗
69. Photochemical release of methotrexate from folate receptor-targeting PAMAM dendrimer nanoconjugate10.1039/c2pp05355a ↗
70. A photochemical approach for controlled drug release in targeted drug delivery10.1016/j.bmc.2011.12.020 ↗
71. Tumoritropic and lymphotropic principles of macromolecular drugs
72. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs
73. Passive targeting of nanoparticles to cancer: a comprehensive review of the literature10.3892/mco.2014.356 ↗
74. High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules
75. Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis10.1111/j.1349-7006.2004.tb03219.x ↗
76. Targeting folate receptor alpha for cancer treatment10.18632/oncotarget.9651 ↗
77. Transferrin receptor-mediated endocytosis: a useful target for cancer therapy10.1007/s00232-014-9637-0 ↗
78. The role of lipoproteins in the delivery of tumour-targeting photosensitizers10.1016/0020-711X(93)90684-7 ↗
79. Expert opinion: responsive polymer nanoparticles in cancer therapy10.1016/j.ejpb.2011.08.004 ↗
80. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery10.1016/j.jconrel.2010.08.027 ↗
81. Polyamidoamine dendrimers as gene delivery carriers in the inner ear: how to improve transfection efficiency10.3892/etm.2011.296 ↗
82. Dendrimer-stabilized gold nanostars as a multifunctional theranostic nanoplatform for CT imaging, photothermal therapy, and gene silencing of tumors10.1002/adhm.201600923 ↗
83. Partially PEGylated dendrimer-entrapped gold nanoparticles: a promising nanoplatform for highly efficient DNA and siRNA delivery10.1039/C6TB00710D ↗
84. Partially acetylated dendrimer-entrapped gold nanoparticles with reduced cytotoxicity for gene delivery applications10.1166/jnn.2015.9618 ↗
85. Gene delivery using dendrimer-entrapped gold nanoparticles as nonviral vectors10.1016/j.biomaterials.2011.12.045 ↗
86. Computer simulation of DNA condensation by PAMAM dendrimer10.1002/mats.201700070 ↗
87. Synthesis and characterization of a PAMAM dendrimer nanocarrier functionalized by SRL peptide for targeted gene delivery to the brain10.1016/j.ejps.2015.06.024 ↗
88. SRL-coated PAMAM dendrimer nano-carrier for targeted gene delivery to the glioma cells and competitive inhibition by lactoferrin
89. Bundling and aggregation of DNA by cationic dendrimers10.1021/bm1013102 ↗
90. Design and biomedical applications of poly (amidoamine)-dendrimer-based hybrid nanoarchitectures10.1002/smtd.201700224 ↗
91. Dendrimer-entrapped gold nanoparticles modified with folic acid for targeted gene delivery applications10.1039/c3bm60138b ↗
92. Poly (amidoamine)-based dendrimer/siRNA complexation studied by computer simulations: effects of pH and generation on dendrimer structure and siRNA binding10.1002/mabi.201100276 ↗
93. A combination of guanidyl and phenyl groups on a dendrimer enables efficient siRNA and DNA delivery10.1021/acs.biomac.7b00567 ↗
94. Dendrimer-modified MoS2 nanoflakes as a platform for combinational gene silencing and photothermal therapy of tumors10.1021/acsami.7b03371 ↗
95. Dendrimer-entrapped gold nanoparticles modified with β-cyclodextrin for enhanced gene delivery applications10.1039/C6RA03839E ↗
96. RGD peptide-modified dendrimer-entrapped gold nanoparticles enable highly efficient and specific gene delivery to stem cells10.1021/am508760w ↗
97. Enhanced delivery of therapeutic siRNA into glioblastoma cells using dendrimer-entrapped gold nanoparticles conjugated with β-cyclodextrin10.3390/nano8030131 ↗
98. Endocytosis and exocytosis of nanoparticles in mammalian cells
99. Dendrimer pharmacokinetics: the effect of size, structure and surface characteristics on ADME properties10.2217/nnm.11.67 ↗
100. Uptake, efflux, and mass transfer coefficient of fluorescent PAMAM dendrimers into pancreatic cancer cells10.1016/j.bbamem.2012.09.016 ↗